Actbtm1Npa
Targeted Allele Detail
|
Symbol: |
Actbtm1Npa |
Name: |
actin, beta; targeted mutation 1, Novartis Pharma AG |
MGI ID: |
MGI:3770046 |
Synonyms: |
beta-actin EGFP, TTG4 |
Gene: |
Actb Location: Chr5:142888870-142892509 bp, - strand Genetic Position: Chr5, 81.8 cM
|
Alliance: |
Actbtm1Npa page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:129639
|
Parent Cell Line: |
BALB/c-I (ES Cell)
|
Strain of Origin: |
BALB/cJ
|
|
Allele Type: |
|
Targeted (RMCE-ready, Reporter) |
Mutation: |
|
Insertion
|
|
|
Mutation details: A recombinase-mediated cassette exchange (RMCE) vector consisting of a mutant LoxP site, a promoterless EGFP reporter gene, a neomycin selection cassette and a wt LoxP site was inserted into the ATG translational start site of exon 2. Endogenous gene expression was replaced with EGFP expression as assessed by fluorescent microscopy and immunohistochemistry of brain, heart, liver and other organs. This allele allows for RMCE into the b-actin locus.
(J:129639)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Actb Mutation: |
53 strains or lines available
|
|
Original: |
J:129639 Shmerling D, et al., Strong and ubiquitous expression of transgenes targeted into the beta-actin locus by Cre/lox cassette replacement. Genesis. 2005 Aug;42(4):229-35 |
All: |
7 reference(s) |
|